Stock listing

LSE:0K2H Moleculin Biotech, Inc. Share Price

UK listing (LSE) of Moleculin Biotech, Inc. · home listing NASDAQ:MBRX

Follow Moleculin Biotech, Inc. into a list and get an email when it puts out news.

Share price · LSE:0K2H

$0.266 USD -0.027 (-9.3%)

Close on Oct 19, 2026

Day range
$0.233 – $0.312 USDOct 19, 2026
Volume
9,568 sharesOct 19, 2026
Moleculin Biotech, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MBRX · Home$7.90 USD-0.82 (-9.4%)31,717$8.80$9.00$7.90$8.72Close on Oct 30, 2026
LSE:0K2H$0.266 USD-0.027 (-9.3%)9,568$0.292$0.312$0.233$0.293Close on Oct 19, 2026
Ticker
LSE:0K2H
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LSE
Currency
USD

What changed lately

Calls

Replays

  • Moleculin Biotech (NASDAQ:MBRX) Q1 2025 Earnings Call

    Wed, May 14, 2025 · 8:30 AM ET

    Watch Transcript
  • Moleculin Biotech (NASDAQ:MBRX) Q4 2024 Earnings Call

    Mon, Mar 24, 2025 · 8:30 AM ET

    Watch Transcript
  • Moleculin Biotech (NASDAQ:MBRX) Q3 2024 Earnings Call

    Mon, Nov 11, 2024 · 8:30 AM ET

    Watch Transcript

Latest news

All Moleculin Biotech, Inc. news

Financings

  • Not stated

    Aug 14, 2026

    Closed: US$9.3M raised

    Use of proceeds: To support planned operations into the first quarter of 2027

    Closed Aug 14, 2026

Read by 6ix AI from the company's releases

Decks

Moleculin Biotech, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
44 in the last 12 months · 245 in all · newest Oct 30, 2026 · oldest 2019
Calls
10 calls with a replay · 10 with a transcript · latest May 14, 2025
Decks
53 decks · latest Oct 16, 2026

Where Moleculin Biotech, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MBRX · Home listingNASDAQUnited StatesUSD
BOATS:MBRXBOATSUnited StatesUSD
LSE:0K2H · This pageLSEUnited KingdomUSD
gettex:MOL0gettexGermanyEUR
Frankfurt:MOL0FrankfurtGermanyEUR
Munich:MOL0MunichGermanyEUR
Lang & Schwarz:A41SETLang & SchwarzGermanyEUR

Log in to ask 6ix AI your own questions about Moleculin Biotech, Inc.